Additional Treatment Benefits For Patients: Our Exclusive License Agreement

In Brief: The work of Dr. Joanne Kurtzberg and her colleagues at Duke University aims to bring novel cord blood and cord tissue-based cellular therapies to the clinic. Per the license agreement, additional patients will be provided access to cord blood and cord tissue treatments under Investigational New Drug Applications (INDs) currently held by Duke [...]

Published April 22, 2021 at 10:40PM. Read full article at Stem Cells in the News Portal.